Search Results 91-100 of 16184 for pharmacogenetics
study expands previous pharmacogenetic research completed by the Mayo ... Applying pharmacogenetics for an individualized treatment approach on a ...
Corifact™ or Tretten® is a man-made protein produced to replicate the naturally occurring factor XIII in the body. It is used to stop bleeding by helping the ...
The center has established service lines in cancer, rare and undiagnosed diseases, pharmacogenomics, and predictive genomics and is integrating these services ...
For the first time, a team of scientists led by the National Institutes of Health has finished sequencing an entire human genome — all of the roughly 3 billion ...
The Center for Individualized Medicine aligns its programs across four pillars: Functional Omics, Digital Omics, Population Omics and Rare Disease Omics.
About this study. Tapestry is a Mayo Clinic research study, which includes receiving genetic sequencing data from Helix, up to the full whole exome dataset.
... pharmacogenetic studies in clinical protocols to include development and validation of assays for genetic variants of proteins associated with drug response.
In one study, she investigates a series of biomarkers related to the initial treatment for patients with estrogen receptor-positive, or ER+, breast cancer with ...
From Alzheimer's disease and asthma to diabetes and a chemotherapy drug, researchers at Mayo Clinic are tapping the Sangre Por Salud (Spanish for "Blood for ...
Pharmacogenetic testing (such as cytochrome P450 2D6 and 2C19, serotonin transporter gene); Transcranial magnetic stimulation; Psychotherapy techniques (such ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.